A Randomized Controlled Trial on the Efficacy and Safety of Low-Dose hCG in a Short Protocol with GnRH Agonist and Ovarian Stimulation with Recombinant FSH (rFSH) During the Follicular Phase in Infertile Women Undergoing ART
Sign Up to like & getrecommendations! Published in 2021 at "Reproductive Sciences"
DOI: 10.1007/s43032-021-00683-3
Abstract: Τhis study aims to investigate whether the addition of low-dose hCG throughout stimulation in infertile women undergoing IVF improves IVF outcome parameters. This is a prospective, multicenter, randomized, double-blind, placebo-controlled, Phase IIIb clinical study, conducted… read more here.
Keywords: phase; low dose; hcg; gnrh agonist ... See more keywords
Effect of GnRH agonist and letrozole treatment in women with recurrent implantation failure.
Sign Up to like & getrecommendations! Published in 2019 at "Fertility and sterility"
DOI: 10.1016/j.fertnstert.2019.03.021
Abstract: OBJECTIVE To compare the influence of dual suppression with the use of GnRH agonist plus aromatase inhibitor compared with suppression with the use of GnRH agonist alone or no suppression at all in patients with… read more here.
Keywords: treatment; agonist plus; gnrh agonist; received gnrh ... See more keywords
GnRH agonist triggering followed by 1500 IU of HCG 48 h after oocyte retrieval for luteal phase support.
Sign Up to like & getrecommendations! Published in 2020 at "Reproductive biomedicine online"
DOI: 10.1016/j.rbmo.2020.07.024
Abstract: RESEARCH QUESTION Gonadotrophin releasing hormone (GnRH) agonist trigger after GnRH antagonist-based ovarian stimulation protocol for IVF is gaining popularity, because it prevents ovarian hyperstimulation syndrome and allows for near physiological LH and FSH surges. A… read more here.
Keywords: support; study; gnrh agonist; oocyte retrieval ... See more keywords
Daily GnRH agonist treatment delays the development of reproductive physiology and behavior in male rats
Sign Up to like & getrecommendations! Published in 2021 at "Hormones and Behavior"
DOI: 10.1016/j.yhbeh.2021.104982
Abstract: The present study was designed to examine the effects of suppressing pubertal onset with leuprolide acetate, a gonadotropin releasing hormone (GnRH) agonist. Starting on postnatal day (PD) 25, male Long-Evans rats were injected daily with… read more here.
Keywords: treatment; gnrh agonist; physiology; agonist treatment ... See more keywords
O-293 The GnRH-agonist trigger alone can be used for egg maturation in altruistic egg donors using long-acting reversible contraceptives without compromising the outcome
Sign Up to like & getrecommendations! Published in 2022 at "Human Reproduction"
DOI: 10.1093/humrep/deac106.086
Abstract: Does use of long-acting reversible contraceptives (LARC) compromise the efficacy of a GnRH agonist trigger in egg donors? Using a GnRH-agonist trigger in altruistic egg donors using LARCs does not appear to compromise oocyte yield… read more here.
Keywords: egg; group; agonist trigger; group iqr ... See more keywords
Cumulative live birth rates after one ART cycle including all subsequent frozen–thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols
Sign Up to like & getrecommendations! Published in 2017 at "Human Reproduction"
DOI: 10.1093/humrep/dew358
Abstract: STUDY QUESTION Are cumulative live birth rates (CLBRs) similar in GnRH-antagonist and GnRH-agonist protocols for the first ART cycle including all subsequent frozen-thaw cycles from the same oocyte retrieval? SUMMARY ANSWER The chances of at… read more here.
Keywords: gnrh agonist; gnrh antagonist; cycle; live birth ... See more keywords
Characteristics and long-term outcomes of perineal endometriosis
Sign Up to like & getrecommendations! Published in 2020 at "Medicine"
DOI: 10.1097/md.0000000000020638
Abstract: Abstract To summarize the clinical features, diagnosis, and treatments of perineal endometriosis (PEM). We retrospectively studied the clinical data of 35 patients with PEM between April 2012 and December 2018 in West China Second Hospital.… read more here.
Keywords: perineal endometriosis; pem; gnrh agonist; agonist group ... See more keywords
A Case of Switching from GnRH Agonist to Antagonist for Castration Resistant Prostate Cancer Control
Sign Up to like & getrecommendations! Published in 2019 at "Case Reports in Oncology"
DOI: 10.1159/000502859
Abstract: GnRH antagonist and GnRH agonist are widely used as androgen deprivation therapy for metastatic prostate cancer. A previous report demonstrated that patients with PSA levels of >20 ng/mL using GnRH antagonists showed favorable outcomes in… read more here.
Keywords: gnrh agonist; psa level; prostate cancer; case ... See more keywords
Quantitative proteomic analysis of GnRH agonist treated GBM cell line LN229 revealed regulatory proteins inhibiting cancer cell proliferation
Sign Up to like & getrecommendations! Published in 2022 at "BMC Cancer"
DOI: 10.1186/s12885-022-09218-8
Abstract: Background Gonadotropin-releasing hormone (GnRH) receptor, a rhodopsin-like G-protein coupled receptor (GPCR) family member involved in GnRH signaling, is reported to be expressed in several tumors including glioblastoma multiforme (GBM), one of the most malignant and… read more here.
Keywords: analysis; gnrh agonist; cell; cell proliferation ... See more keywords
Oxidative stress and biochemical markers in prenatally androgenized sheep after neonatal treatment with GnRH agonist
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Inflammation Research"
DOI: 10.2147/jir.s190260
Abstract: Background Disruption of the balance between the production of ROS and their removal through enzymatic and non-enzymatic (antioxidant) processes has been proposed as a new mechanism in the pathology of polycystic ovary syndrome (PCOS). Evidence… read more here.
Keywords: prenatally androgenized; gnrh agonist; treatment; neonatal treatment ... See more keywords
Severe Multiple Sclerosis Manifesting upon GnRH Agonist Therapy for Uterine Fibroids
Sign Up to like & getrecommendations! Published in 2020 at "Internal Medicine"
DOI: 10.2169/internalmedicine.4839-20
Abstract: This case concerned a 39-year-old woman diagnosed with uterine fibroids. Upon initiation of gonadotropin-releasing hormone (GnRH) agonist therapy, she experienced various neurological deficits but did not seek medical attention because of gradual spontaneous symptom improvement.… read more here.
Keywords: agonist therapy; gnrh agonist; multiple sclerosis; therapy ... See more keywords